Nasal T/NK cell lymphoma: Report of 3 cases involving the palate

Journal of Oral and Maxillofacial Surgery

Volumn 58, Issue 11, 2000, Pages 1323-1327

  Tsang, W M ^a   Tong, A C K ^a   Lam, K Y ^a   Tideman, H ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CASE REPORT; CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JAW TUMOR; LABORATORY TEST; LYMPHOID CELL; MALE; MOUTH ULCER; NATURAL KILLER CELL; NOSE TUMOR; T CELL LYMPHOMA;

EID: 0033766177     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1053/joms.2000.16645     Document Type: Article

References (33)

1. Photographs of a case of rapid destruction of the nose and face
2. Progressive lethal granulomatous ulceration of the nose
3. Lethal midline granuloma: Is it a pathological entity?
4. Centrofacial malignant granuloma: Clincopathologic study of 40 cases and review of literature
5. Sinonasal lymphoma presenting as a lethal midline granuloma: Case report
6. Heterogeneous malignant non-Hodgkin's lymphomas as a causative disorder in lethal midline granuloma
7. Sinonasal lymphomas
8. Diagnosis of malignant lymphomas of the nasal cavity, paranasal sinuses and nasopharynx
9. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity: Clinical and immunologic aspects
10. Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period
11. Nasopharyngeal and nasal malignant lymphoma: A clinicopathological study of 54 cases
12. Most nasal and nasopharyngeal lymphomas are peripheral T-cell neoplasms
13. Peripheral T-cell lymphoma presenting primarily as lethal midline granuloma
14. The non-Hodgkin's lymphoma classification project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
15. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
16. Detection of Epstein-Barr virus in malignant lymphomas of the upper aerodigestive tract
17. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in Western China
18. Nasal lymphomas in Peru: High incidence of T-cell immunophenotype and Epstein-Barr virus infection
19. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protien-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico
20. Extranodal peripheral T-cell and NK-cell neoplasms
21. Nasal T-cell lymphoma
22. Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas
23. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases and immunophenotypic studies of 16 cases
24. Application of a T-cell receptor antibody βF1 for immunophenotypic analysis of malignant lymphomas
25. Polymorphic reticulosis: A reappraisal
26. Report of the workshop on nasal and related extranodal angiocentric T/NK cell lymphoma
27. Lymphomatoid granulomatosis and angiocentric lymphoma: A spectrum of post-thymic T-cell proliferations
28. CD56-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules and angiocentricity
29. The role of morphologic feature, phenotype, genotype, and anatomic site in defining extranodal T-cell or NK-cell neoplasms
30. Nasal lymphoma Results of local radiotherapy with or without chemotherapy
31. Peripheral T cell lymphomas have a worse prognosis than B-cell lymphoma: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen
32. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
33. Non-nasal lymphoma expressing the natural killer cell marker, CD 56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm